Search by property

This page provides a simple browsing interface for finding entities described by a property and a named value. Other available search interfaces include the page property search, and the ask query builder.

List of results

• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 29 Paragraph 2  + (Article 29 Paragraph 2)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 29 Paragraph 3-5  + (Article 29 Paragraph 3-5)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 29 Paragraph 6-8  + (Article 29 Paragraph 6-8)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 29A  + (Article 29A)
• Reference:GBR Directive 2001/20/EC 04-Apr-2001 Article 3  + (Article 3)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 3 (1) - (5)  + (Article 3 (1) - (5))
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 3 (6) - (11)  + (Article 3 (6) - (11))
• Reference:EU Regulation (EU) 910/2014 - electronic identification 17-Sep-2014 Article 3 Paragraph 10  + (Article 3 Paragraph 10)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 30-001  + (Article 30)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 30-002  + (Article 30)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 31  + (Article 31)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 31 Paragraph 1  + (Article 31 Paragraph 1)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 31 Paragraph 2-3  + (Article 31 Paragraph 2-3)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 32  + (Article 32)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 32 Paragraph 1  + (Article 32 Paragraph 1)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 32 Paragraph 2-3  + (Article 32 Paragraph 2-3)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 33  + (Article 33)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 33  + (Article 33)
• Reference:FRA Constitution du 4 octobre 1958 10-Mar-2024 Article 34  + (Article 34)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 34  + (Article 34)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 34  + (Article 34)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 35  + (Article 35)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 35 Paragraph 1  + (Article 35 Paragraph 1)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 35 Paragraph 2-3  + (Article 35 Paragraph 2-3)
• Reference:FRA Constitution du 4 octobre 1958 10-Mar-2024 Article 37  + (Article 37)

• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 37 Paragraph 1 – 7  + (Article 37 Paragraph 1 – 7)

• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 37 Paragraph 4  + (Article 37 Paragraph 4)
• Reference:FRA Constitution du 4 octobre 1958 10-Mar-2024 Article 38  + (Article 38)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 38  + (Article 38)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 4  + (Article 4)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 41-001  + (Article 41)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 41-002  + (Article 41)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 42  + (Article 42)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 43  + (Article 43)
• Reference:EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Article 47  + (Article 47)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 47-001  + (Article 47)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 47-002  + (Article 47)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 47-003  + (Article 47)
• Reference:EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Article 48  + (Article 48)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 48  + (Article 48)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 49  + (Article 49)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 5  + (Article 5)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 5-6  + (Article 5-6)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 50  + (Article 50)
• Reference:EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Article 51  + (Article 51)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 51  + (Article 51)
• Reference:GBR The Human Medicines Regulations 2012 01-Jan-2025 Article 51B  + (Article 51B)
• Reference:EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Article 52  + (Article 52)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 52  + (Article 52)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 53  + (Article 53)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 54  + (Article 54)